GHRP-6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Price range: $34.99 through $48.99

SKU: 214412-1-1-5-1-4-1-2-2-1-9-1-3 Category:
  • Official retailer
  • Quality guaranteed
  • Within 2 Days Delivery
  • 99% Purified

Purity You Can Trust. Results You Can Feel.

Shop Peptides Direct offers premium-grade, third-party tested peptides for research and peak performance. Experience uncompromising quality with fast, discreet shipping nationwide.

High-Level Summary

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide belonging to the family ofย growth hormone secretagogues. It is widely studied in laboratory environments for its interaction with theย growth hormone secretagogue receptor (GHS-R1a), a receptor involved in endocrine signaling associated with growth hormone regulation.

As a ghrelin receptor agonist, GHRP-6 is frequently used in experimental research investigatingย neuroendocrine signaling, hormonal feedback mechanisms, and metabolic regulation models. The peptideโ€™s receptor activity enables researchers to study how stimulation of the GHS-R receptor influences signaling pathways involved in hormone secretion and endocrine system communication.

In laboratory studies, GHRP-6 has been used in research models examining:

  • Growth hormone secretion pathways
    โ€ข Ghrelin receptor activation mechanisms
    โ€ข Endocrine signaling within the hypothalamic-pituitary axis
    โ€ข Appetite-related signaling pathways
    โ€ข Hormonal interaction with metabolic regulation systems

Because of its well-characterized receptor activity and relatively simple peptide structure, GHRP-6 is commonly utilized in controlled endocrine research environments.

Product Details

Form: Lyophilized peptide powder
Peptide Class: Growth hormone secretagogue hexapeptide
Purity: โ‰ฅ99% (analytically verified)
CAS Number: 87616-84-0
Peptide ID: LP-G6-15
Certificate of Analysis: Available upon request
Intended Use: Laboratory research only

Mechanism of Action (MOA)

GHRP-6 exerts its activity primarily through interaction with theย growth hormone secretagogue receptor (GHS-R1a), a receptor that also responds to the endogenous hormone ghrelin.

Ghrelin Receptor Activation

When GHRP-6 binds to the GHS-R receptor in experimental models, it can initiate intracellular signaling pathways that stimulate growth hormone secretion from the anterior pituitary.

Endocrine Signaling Pathways

The receptor activation triggered by GHRP-6 is used in research models examining communication between the hypothalamus and pituitary gland, which plays a central role in endocrine regulation.

Appetite-Associated Signaling

Because the ghrelin receptor is also involved in appetite signaling, GHRP-6 is frequently used in research investigating pathways associated with energy balance and feeding behavior.

Hormonal and Metabolic Interaction Models

Growth hormone signaling interacts with multiple metabolic systems. For this reason, GHRP-6 has been studied in experimental models examining endocrine-metabolic signaling relationships.

These mechanistic properties make GHRP-6 a useful tool in laboratory research focused on hormonal pathway dynamics.

Research Applications

GHRP-6 is commonly utilized in laboratory research investigating:

  • Growth hormone secretion models
    โ€ข Ghrelin receptor signaling pathways
    โ€ข Hypothalamic-pituitary axis studies
    โ€ข Appetite signaling mechanisms
    โ€ข Neuroendocrine pathway research
    โ€ข Hormone-related metabolic pathway investigation

Researchers are responsible for designing appropriate experimental protocols and ensuring compliance with institutional regulations.

Structural Characteristics

GHRP-6 is aย synthetic hexapeptide, meaning it is composed of six amino acids arranged in a sequence designed to interact with the growth hormone secretagogue receptor.

Its compact peptide structure contributes to its stability and receptor binding properties in experimental models.

Because of its structural similarity to other secretagogue peptides, GHRP-6 is often studied alongside compounds such as GHRP-2, CJC-1295, and Ipamorelin in laboratory endocrine research systems.

Product Specifications

Form: Lyophilized powder
Peptide Class: Growth hormone secretagogue
Purity: โ‰ฅ99% analytical verification
CAS Number: 87616-84-0
Peptide ID: LP-G6-15
Packaging: Sterile research vial
Storage: Refrigerated (2โ€“8ยฐC)

Quality Assurance & Testing

Each batch of GHRP-6 undergoes analytical verification to ensure research-grade purity and consistency.

Quality verification may include:

  • High-Performance Liquid Chromatography (HPLC) purity testing
    โ€ข Identity confirmation analysis
    โ€ข Batch traceability documentation
    โ€ข Controlled lyophilization procedures
    โ€ข Sterile packaging verification

Certificates of Analysis are available upon request.

Handling & Storage Guidelines

GHRP-6 is supplied as aย lyophilized peptide powderย for laboratory research.

Recommended storage conditions:

  • Store refrigerated atย 2โ€“8ยฐC
    โ€ข Protect from direct light exposure
    โ€ข Avoid repeated temperature cycling
    โ€ข Use proper laboratory handling techniques

The compound is supplied dry and is not pre-reconstituted.

Legal & Compliance Notice

This product is intended strictly forย laboratory research purposes only.

Not for human consumption.
Not for veterinary use.
Not for therapeutic or diagnostic applications.

By purchasing this product, the buyer acknowledges compliance with all applicable laws and research regulations.

What is GHRP-6?

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide studied in laboratory environments for its interaction with ghrelin receptors and endocrine signaling pathways.

What class of peptide is GHRP-6?

GHRP-6 belongs to the class of peptides known asย growth hormone secretagogues, which are compounds investigated for their ability to stimulate growth hormone signaling pathways in experimental models.

What form does your GHRP-6 come in?

Our GHRP-6 is supplied as aย sterile lyophilized powderย intended for laboratory research use.

What is the CAS number for GHRP-6?

The CAS number for GHRP-6 isย 87616-84-0.

Is GHRP-6 intended for human use?

No. GHRP-6 is intended strictly forย laboratory research purposes only.

How should GHRP-6 be stored?

Store GHRP-6 refrigerated atย 2โ€“8ยฐC, protected from light, and handled according to laboratory best practices.

What purity standard is GHRP-6 produced to?

Each batch is analytically verified toย โ‰ฅ99% purityย and supported by batch documentation and COA availability.

How do I request a Certificate of Analysis?

Certificates of Analysis may be requested by contacting support and referencing your order details.

Why choose Shop Peptides Direct for multi-peptide formulations?

Shop Peptides Direct emphasizes analytical transparency, batch-level verification, controlled sourcing, and research-focused quality assurance.

GHRP-6 Dosage Protocol (2 mg, 5 mg & 10 mg Vials)

Quickstart Highlights

GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a)[1][2]. It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits[3]. This educational protocol presents a three-times-daily subcutaneous approach using practical dilutions for precise insulin-syringe measurements.

  • Multiple vial sizes: Choose from 2 mg, 5 mg, or 10 mg vials to match your protocol needs.
  • Daily dose range: 300โ€“900 mcg total (split into 3 doses with gradual titration).
  • Convenient dosing: Each vial size has optimized reconstitution for easy insulin syringe measurements.
  • Storage: Lyophilized: freeze at โˆ’20 ยฐC (โˆ’4 ยฐF); after reconstitution, refrigerate at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF) and use within 7 days.

Dosing & Reconstitution Guide

Educational guide for all vial sizes - choose your optimal concentration

2 mg Vial Protocol (3 mL = ~0.67 mg/mL)

Week/Phase Dose per Injection Units (per injection) (mL)
Weeks 1โ€“2 100 mcg 15 units (0.15 mL) Weeks 3โ€“4 200 mcg 30 units (0.30 mL) Weeks 5โ€“12 300 mcg 45 units (0.45 mL)

Reconstitution: Add 3.0 mL bacteriostatic water โ†’ ~0.67 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ‰ˆ 6.7 mcg on a Uโ€‘100 insulin syringe.

5 mg Vial Protocol (3 mL = ~1.67 mg/mL)

Week/Phase Dose per Injection Units (per injection) (mL)
Weeks 1โ€“2 100 mcg 6 units (0.06 mL)
Weeks 3โ€“4 200 mcg 12 units (0.12 mL)
Weeks 5โ€“12 300 mcg 18 units (0.18 mL)

Reconstitution: Add 3.0 mL bacteriostatic water โ†’ ~1.67 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ‰ˆ 16.7 mcg on a Uโ€‘100 insulin syringe.

10 mg Vial Protocol (3 mL = ~3.33 mg/mL)

Week/Phase Dose per Injection Units (per injection) (mL)
Weeks 1โ€“2 100 mcg 3 units (0.03 mL)
Weeks 3โ€“4 200 mcg 6 units (0.06 mL)
Weeks 5โ€“12 300 mcg 9 units (0.09 mL)

Reconstitution: Add 3.0 mL bacteriostatic water โ†’ ~3.33 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ‰ˆ 33.3 mcg on a Uโ€‘100 insulin syringe.

Reconstitution Steps (All Vial Sizes)

  1. Draw appropriate volume of bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to minimize foaming; avoid shaking.
  3. Gently swirl or roll the vial until the powder is fully dissolved.
  4. Label the vial with the reconstitution date and refrigerate at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF), protected from light.
  5. Use reconstituted solution within 7 days for maximum potency and safety[8].

Frequency: Inject three times daily subcutaneously, spaced at least 4 hours apart (morning, midday, bedtime). GHRP-6 has a short half-life of approximately 2.5 hours[4], making multiple daily injections more effective than once-daily dosing for sustained GH elevation[5]. Each injection should be administered on an empty stomach (2โ€“3 hours after meals, 30 minutes before eating) to maximize GH release[6]. For โ‰ค10-unit (โ‰ค0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Supplies Needed

Plan based on a 12-week protocol with three-times-daily injections and gradual titration to 300 mcg per dose.

  • Peptide Vials (GHRP-6): Choose your preferred vial size (2 mg, 5 mg, or 10 mg). Estimated needs for 12 weeks:
    • 2 mg vials: 32 vials
    • 5 mg vials: 13 vials
    • 10 mg vials: 7 vials
  • Insulin Syringes (Uโ€‘100): For โ‰ค10-unit doses, 30โ€‘ or 50โ€‘unit syringes recommended for precision.
    • Per week: 21 syringes (3/day ร— 7 days)
    • 12 weeks: 252 syringes โ†’ recommend 3 ร— 100โ€‘count boxes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
    • 2 mg vials (32 vials): 96 mL โ†’ 10 ร— 10 mL bottles
    • 5 mg vials (13 vials): 39 mL โ†’ 4 ร— 10 mL bottles
    • 10 mg vials (7 vials): 21 mL โ†’ 3 ร— 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site per injection.
    • Per week: 42 swabs (2 per injection ร— 3 daily ร— 7 days)
    • 12 weeks: 504 swabs โ†’ recommend 6 ร— 100โ€‘count boxes
  • Sharps Container: 1โ€‘quart container holds ~100 syringes; 3โ€‘quart for 12โ€‘week protocol.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Protocol Overview

Concise summary of the three-times-daily regimen.

  • Goal: Stimulate pulsatile GH release to support muscle growth, fat loss, and recovery[2][7].
  • Schedule: Three subcutaneous injections daily for 8โ€“12 weeks, spaced at least 4 hours apart.
  • Dose Range: 100โ€“300 mcg per injection with gradual titration (300โ€“900 mcg total daily).
  • Vial Options: 2 mg, 5 mg, or 10 mg vials with optimized reconstitution for each size.
  • Storage: Lyophilized frozen at โˆ’20 ยฐC (โˆ’4 ยฐF); reconstituted refrigerated at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF); use within 7 days.

Dosing Protocol

Suggested titration approach with multiple daily doses based on clinical studies[2][3][4][5].

  • Weeks 1โ€“2: 100 mcg per injection, 3ร— daily (300 mcg total) โ€“ establish tolerance.
  • Weeks 3โ€“4: 200 mcg per injection, 3ร— daily (600 mcg total) โ€“ increase GH response.
  • Weeks 5โ€“12: 300 mcg per injection, 3ร— daily (900 mcg total) โ€“ target maintenance dose.
  • Timing: On empty stomach; space injections at least 4 hours apart; wait 30 minutes before eating.
  • Cycle Length: 8โ€“12 weeks; rotate injection sites to prevent tissue irritation.

Storage Instructions

Proper storage preserves peptide quality and potency[8].

  • Lyophilized (powder): Store at โˆ’20 ยฐC (โˆ’4 ยฐF) in dry, dark conditions with desiccant if available.
  • Reconstituted (solution): Refrigerate at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF) and use within 7 days[8]; do not freeze.
  • Avoid freeze-thaw cycles: Do not refreeze reconstituted solution; prepare aliquots if extended storage is needed.
  • Allow vials to reach room temperature before opening to minimize condensation. Protect from light and heat.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a proper sharps container[9].
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and avoid lipohypertrophy[10].
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle to ensure complete delivery.
  • GHRP-6 may increase appetite in some users due to its ghrelin-mimicking properties[11].
  • Document daily doses, timing, and sites to maintain consistency throughout the cycle.

How This Works

GHRP-6 functions as a synthetic ghrelin mimetic by binding to the growth hormone secretagogue receptor (GHS-R1a) in the pituitary gland and hypothalamus[1][12]. This activation triggers acute, pulsatile growth hormone release from somatotroph cells while simultaneously reducing somatostatin's inhibitory brake on GH secretion[3]. Unlike continuous GH administration, GHRP-6 maintains physiological feedback controlsโ€”as GH and IGF-1 levels rise, endogenous somatostatin increases to prevent excessive elevation, keeping GH pulses within normal physiologic ranges[5].

Beyond its endocrine effects, GHRP-6 exhibits cytoprotective properties through interactions with the CD36 receptor on immune and muscle cells[2][13]. This secondary pathway activates cell-survival signaling cascades (such as PI3K/Akt) that help protect tissues from oxidative stress and inflammation, explaining many of GHRP-6's observed tissue-protective benefits in preclinical models including cardioprotection, neuroprotection, and anti-fibrotic effects[2][14].

Potential Benefits & Side Effects

Observations from clinical and preclinical literature[1][2][3][7][11][14][15][16][17][18][19].

Potential Benefits:

  • Muscle Growth & Fat Loss: Elevated GH and IGF-1 levels support increased lean body mass and reduced fat mass over time[7][15].
  • Enhanced Recovery: Improved sleep architecture (increased slow-wave sleep) and faster tissue repair[16].
  • Appetite Stimulation: May increase hunger due to ghrelin receptor activation, potentially beneficial for weight gain goals[11].
  • Tissue Protection: Preclinical studies show cytoprotective effects including reduced scar formation, cardioprotection, and neuroprotection[2][14][17].
  • Joint & Connective Tissue Health: May support collagen synthesis and connective tissue repair through elevated IGF-1[7].

Potential Side Effects:

  • Transient mild increases in cortisol and ACTH (typically not clinically significant)[18].
  • Increased appetite and potential water retention.
  • Occasional injection-site reactions (redness, itching, mild swelling).
  • Possible transient dizziness or flushed feeling immediately after injection due to rapid GH spike.
  • Generally well-tolerated in human trials at research doses with no major safety concerns reported[19].

Lifestyle Factors

Complementary strategies for optimizing outcomes.

  • Nutrition: Maintain adequate protein intake (1.6โ€“2.2 g/kg body weight) to support anabolic processes. Time carbohydrate and fat intake away from injections to maximize GH release[6].
  • Training: Combine resistance training with moderate cardiovascular activity to leverage elevated GH/IGF-1 for muscle growth and fat oxidation.
  • Sleep: Prioritize 7โ€“9 hours of quality sleep; GHRP-6's effects on sleep architecture may enhance recovery[16].
  • Hydration: Maintain proper hydration to support metabolic processes and minimize water retention.
  • Stress Management: Chronic stress can interfere with GH secretion; incorporate stress-reduction techniques.

Injection Technique

General subcutaneous guidance from clinical bestโ€‘practice resources[9][10][20][21][22].

  • Preparation: Clean the vial stopper and chosen skin site with separate alcohol swabs; allow both to dry completely before proceeding[9].
  • Drawing the dose: Use a new sterile insulin syringe; draw the calculated units and check for air bubbles. For โ‰ค10โ€‘unit doses, 30โ€‘ or 50โ€‘unit syringes improve readability.
  • Site selection: Rotate between abdomen (2+ inches from navel), outer thighs, and upper arms. Avoid repeatedly injecting the same spot[10][22].
  • Technique: Pinch a skinfold; insert needle at a 45โ€“90ยฐ angle into subcutaneous tissue (angle depends on needle length and body fat)[20][21].
  • Administration: Do not aspirate for subcutaneous injections. Inject slowly and steadily; hold for a few seconds before withdrawing[20].
  • Disposal: Immediately dispose of used syringes and needles in a puncture-proof sharps container. Never reuse needles[9].

Recommended Source

We recommend Shop Peptides Direct for highโ€‘purity GHRP-6 in all vial sizes (2 mg, 5 mg, and 10 mg).

Why Shop Peptides Direct?

  • Highโ€‘purity, thirdโ€‘partyโ€‘tested peptides with batchโ€‘specific Certificates of Analysis (COAs).
  • Consistent, ISOโ€‘aligned handling and quality documentation.
  • Reliable fulfillment with coldโ€‘chain integrity to preserve peptide stability.
  • Transparent testing and verification processes for researchโ€‘grade peptides.
  • Multiple vial sizes to match different protocol needs and durations.

Important Note

This content is for educational purposes only and is not medical advice. GHRP-6 is for research use only. Not for human consumption. Always consult with qualified professionals before starting any peptide research protocol. Individual responses may vary, and proper medical supervision is essential for safety and efficacy monitoring.

References

  • European Journal of Endocrinology (1997) โ€” Growth hormone-releasing peptides: comprehensive review of GHRP mechanisms and effects
  • Clinical Medicine Insights: Cardiology (2017) โ€” Synthetic GHRPs: historical appraisal of cytoprotective effects and mechanisms
  • Wikipedia โ€“ GHRP-6 โ€” Structure, pharmacology, and mechanism of action overview
  • European Journal of Pharmaceutical Sciences (2013) โ€” Pharmacokinetic study of GHRP-6 in healthy male volunteers
  • Shop Peptides Direct โ€“ Quality Assurance โ€” Third-party testing and batch documentation

Reviews

There are no reviews yet.

Be the first to review “GHRP-6”

Your email address will not be published. Required fields are marked *

RELATED PRODUCTS